Description: Nunzia Pharmaceutical Corporation operates as a pharmaceutical and nutraceutical company. It owns the right to manufacture, market, and distribute a drug, NUNZIA that treats autism, fragile X, ADHD, and PTSD. The company was founded in 1986 and is based in Long Beach, California.
Home Page: www.nunziapharma.com
1627 West 14th Street
Long Beach,
CA
90813
United States
Phone:
714 609 9117
Officers
| Name | Title |
|---|---|
| Mr. Michael Mitsunaga | President, CFO, Treasurer, Secretary & Director |
| Dr. Shujie Cui | Chief Medical Officer, Chief Science Officer & Director |
| Ms. Sara P. Gonzales | CEO & Director |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |